nivolumab
bms
['nadim ii', 'nadim', 'nivolumab', 'nsclc', 'nivo', 'sclc']
 el dr. presenta "nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage iiia nsclc: primary endpoint results of pathological complete response (pcr) from phase ii nadim ii trial" en #asco22 
GECP/SLCG
Desde 1991 investigando para avanzar en curación y supervivencia al #cancerdepulmon 
#LungResearch #GECPResearch #CancerResearch